Validation of the VE1 immunostain for theBRAFV600E mutation in melanoma

Intrapatient Homogeneity of BRAFV600E Expression in Melanoma

(2013) Alexander M. Menzies et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Urgent treatment of patients with metastatic melanoma using braf inhibitors in the absence of braf mutation status

(2013) P. Nathan et al.   ANNALS OF ONCOLOGY

Detection ofBRAFp.V600E Mutations in Melanoma by Immunohistochemistry Has a Good Interobserver Reproducibility

(2013) Cristi Marin et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

BRAFV600E protein expression and outcome from BRAF inhibitor treatment in BRAF V600E metastatic melanoma

(2013) J S Wilmott et al.   BRITISH JOURNAL OF CANCER

Assessment of clinical parameters associated with mutational status in metastatic malignant melanoma: a single-centre investigation of 141 patients

(2013) M. Schlaak et al.   BRITISH JOURNAL OF DERMATOLOGY

Clonal BRAF Mutations in Melanocytic Nevi and Initiating Role of BRAF in Melanocytic Neoplasia

(2013) Iwei Yeh et al.   JNCI-Journal of the National Cancer Institute

Application of a BRAF V600E Mutation-specific Antibody for the Diagnosis of Hairy Cell Leukemia

(2012) Mindaugas Andrulis et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Combined BRAFV600E-positive Melanocytic Lesions With Large Epithelioid Cells Lacking BAP1 Expression and Conventional Nevomelanocytes

(2012) Klaus J. Busam et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Immunohistochemistry Is Highly Sensitive and Specific for the Detection of V600E BRAF Mutation in Melanoma

(2012) Georgina V. Long et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Immunohistochemical Analysis of BRAFV600E Expression of Primary and Metastatic Melanoma and Comparison With Mutation Status and Melanocyte Differentiation Antigens of Metastatic Lesions

(2012) Klaus J. Busam et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

DNA Methylation Screening Identifies Driver Epigenetic Events of Cancer Cell Survival

(2012) Daniel D. De Carvalho et al.   CANCER CELL

Molecular Testing in Melanoma

(2012) Melissa Ann Wilson et al.   CANCER JOURNAL

Molecular testing in malignant melanoma

(2012) Allie H. Grossmann et al.   DIAGNOSTIC CYTOPATHOLOGY

Detection of BRAF p.V600E Mutations in Melanomas

(2012) Emeline Colomba et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

RASMutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors

(2012) Fei Su et al.   NEW ENGLAND JOURNAL OF MEDICINE

Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody

(2011) David Capper et al.   ACTA NEUROPATHOLOGICA

Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma

(2011) Genevieve Schindler et al.   ACTA NEUROPATHOLOGICA

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

(2011) Paul B. Chapman et al.   NEW ENGLAND JOURNAL OF MEDICINE

The “SWOT” of BRAF Inhibition in Melanoma: RAF Inhibitors, MEK Inhibitors or Both?

(2011) Moriah H. Nissan et al.   Current Oncology Reports

RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF

(2010) Poulikos I. Poulikakos et al.   NATURE

RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth

(2010) Georgia Hatzivassiliou et al.   NATURE

COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

(2010) S. A. Forbes et al.   NUCLEIC ACIDS RESEARCH